APA (7th ed.) Citation

Jahan, F., Penna, L., Luostarinen, A., Veltman, L., Hongisto, H., Lähteenmäki, K., . . . Kerkelä, E. (2024). Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts. Scientific Reports, 14(1), 1. https://doi.org/10.1038/s41598-024-76791-2

Chicago Style (17th ed.) Citation

Jahan, Farhana, et al. "Automated and Closed Clinical-grade Manufacturing Protocol Produces Potent NK Cells Against Neuroblastoma Cells and AML Blasts." Scientific Reports 14, no. 1 (2024): 1. https://doi.org/10.1038/s41598-024-76791-2.

MLA (9th ed.) Citation

Jahan, Farhana, et al. "Automated and Closed Clinical-grade Manufacturing Protocol Produces Potent NK Cells Against Neuroblastoma Cells and AML Blasts." Scientific Reports, vol. 14, no. 1, 2024, p. 1, https://doi.org/10.1038/s41598-024-76791-2.